Dong-A Socio Holdings

Dong-A Socio Holdings is the listed parent company of South Korea's Dong-A Socio Group, a diversified healthcare-focused group spanning prescription pharmaceuticals, consumer healthcare, biologics and nucleic acid CDMO services, medical devices, and logistics. The group's key healthcare subsidiaries include Dong-A ST, Dong-A Pharmaceutical, ST Pharm, and ADC specialist AbTis, giving it exposure to both commercial products and innovative drug development. Through these subsidiaries, the group is active in small molecules, biologics, oligonucleotides, mRNA, and antibody-drug conjugates, with capabilities that extend from discovery and development to manufacturing and commercialization. While Dong-A Socio Holdings itself primarily functions as a strategic holding company, it is closely tied to the operating performance and pipeline of its healthcare affiliates. For a biotech analyst, the investment case is best understood as a healthcare conglomerate and platform owner rather than a single-asset biotech company.